v3.23.1
INTERIM CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Revenue $ 2,201 $ 2,104
Cost of revenue 510 414
Total gross profit 1,691 1,690
Operating expenses:    
Research and development 13,707 13,927
Sales and marketing 518 1,475
General and administrative 8,495 11,560
Restructuring 991 0
Total operating expenses 23,711 26,962
Loss from operations (22,020) (25,272)
Other income (expense), net    
Interest expense (1,464) (1,205)
Interest income 1,284 0
Change in fair value of derivative warrant liabilities (873) 3,771
Change in fair value of earn-out liabilities (281) 5,991
Transaction costs 0 (927)
Total other income (expense), net (1,334) 7,630
Net loss before provision for income taxes (23,354) (17,642)
Provision for income taxes 0 0
Net loss $ (23,354) $ (17,642)
Weighted average shares used in computing net loss per share attributable to common stockholders-basic 124,778 53,692
Weighted average shares used in computing net loss per share attributable to common stockholders-diluted 124,778 53,692
Net loss per share attributable to common stockholders – basic $ (0.19) $ (0.33)
Net loss per share attributable to common stockholders – diluted $ (0.19) $ (0.33)